Royal Bank Of Canada Xenon Pharmaceuticals Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 37,636 shares of XENE stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,636
Previous 36,388 3.43%
Holding current value
$1.46 Million
Previous $1.42 Million 4.37%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.12 - $43.96 $45,077 - $54,862
1,248 Added 3.43%
37,636 $1.48 Million
Q2 2024

Aug 14, 2024
BUY
$36.25 - $43.75 $45,530 - $54,950
1,256 Added 3.58%
36,388 $1.42 Million
Q1 2024

Nov 05, 2024
SELL
$42.66 - $50.04 $53,580 - $62,850
-1,256 Reduced 3.45%
35,132 $1.51 Million
Q1 2024

May 15, 2024
SELL
$42.66 - $50.04 $39,375 - $46,186
-923 Reduced 2.56%
35,132 $1.51 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $256,405 - $415,073
8,934 Added 32.94%
36,055 $1.66 Million
Q3 2023

Nov 14, 2023
BUY
$34.16 - $39.73 $99,747 - $116,011
2,920 Added 12.07%
27,121 $926,000
Q2 2023

Aug 14, 2023
BUY
$34.84 - $43.54 $408,220 - $510,158
11,717 Added 93.86%
24,201 $931,000
Q1 2023

May 15, 2023
SELL
$33.46 - $40.35 $121,995 - $147,116
-3,646 Reduced 22.6%
12,484 $446,000
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $533,224 - $635,966
16,129 Added 1612900.0%
16,130 $636,000
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $30 - $39
1 New
1 $0
Q2 2022

Aug 15, 2022
SELL
$25.44 - $35.16 $618,522 - $854,845
-24,313 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$15.6 - $35.4 $15,600 - $35,400
-1,000 Reduced 3.95%
24,313 $760,000
Q3 2021

Nov 15, 2021
SELL
$14.86 - $19.45 $847 - $1,108
-57 Reduced 0.22%
25,313 $387,000
Q2 2021

Aug 16, 2021
BUY
$16.81 - $20.0 $426,469 - $507,400
25,370 New
25,370 $472,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email